Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ric N Price

Showing results (41-50 of 342) with videos related to

Pageof 35
Sort By:
The American Journal of Tropical Medicine and Hygiene|June 12, 2020
Estimating the Proportion of <i>Plasmodium vivax</i> Recurrences Caused by Relapse: A Systematic Review and Meta-AnalysisRobert J Commons, Julie A Simpson, James Watson, et al.
Plos One|February 14, 2017
Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patientsSue J Lee, Feiko O Ter Kuile, Ric N Price, et al.
The Lancet. Infectious Diseases|June 1, 2010
Artemisinin combination therapy for vivax malariaNicholas M Douglas, Nicholas M Anstey, Brian J Angus, et al.
Diabetes Research and Clinical Practice|October 11, 2015
High burden of diabetic foot infections in the top end of Australia: An emerging health crisis (DEFINE study)Robert J Commons, Claire H Robinson, David Gawler, et al.
Malaria Journal|November 15, 2013
A robust design for identification of the Parasite Clearance EstimatorKris M Jamsen, Stephen B Duffull, Joel Tarning, et al.
The AAPS Journal|July 25, 2014
Making the most of clinical data: reviewing the role of pharmacokinetic-pharmacodynamic models of anti-malarial drugsJulie A Simpson, Sophie Zaloumis, Alysha M DeLivera, et al.
Malaria Journal|October 28, 2017
Statistical methods to derive efficacy estimates of anti-malarials for uncomplicated Plasmodium falciparum malaria: pitfalls and challengesPrabin Dahal, Julie A Simpson, Grant Dorsey, et al.
Advances in Parasitology|December 4, 2012
Chemotherapeutic strategies for reducing transmission of Plasmodium vivax malariaNicholas M Douglas, George K John, Lorenz von Seidlein, et al.
BMC Medical Research Methodology|November 29, 2019
Dealing with indeterminate outcomes in antimalarial drug efficacy trials: a comparison between complete case analysis, multiple imputation and inverse probability weightingPrabin Dahal, Kasia Stepniewska, Philippe J Guerin, et al.
Malaria Journal|October 31, 2021
Opening the policy blackbox: unravelling the process for changing national diagnostic and treatment guidelines for vivax malaria in seven countriesVarunika Ruwanpura, Josselyn Neukom, Koen Peeters Grietens, et al.
Pageof 35

Showing results (41-50 of 342) with videos related to

Sort By:
Pageof 35
The American Journal of Tropical Medicine and Hygiene|June 12, 2020
Estimating the Proportion of <i>Plasmodium vivax</i> Recurrences Caused by Relapse: A Systematic Review and Meta-AnalysisRobert J Commons, Julie A Simpson, James Watson, et al.
Plos One|February 14, 2017
Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patientsSue J Lee, Feiko O Ter Kuile, Ric N Price, et al.
The Lancet. Infectious Diseases|June 1, 2010
Artemisinin combination therapy for vivax malariaNicholas M Douglas, Nicholas M Anstey, Brian J Angus, et al.
Diabetes Research and Clinical Practice|October 11, 2015
High burden of diabetic foot infections in the top end of Australia: An emerging health crisis (DEFINE study)Robert J Commons, Claire H Robinson, David Gawler, et al.
Malaria Journal|November 15, 2013
A robust design for identification of the Parasite Clearance EstimatorKris M Jamsen, Stephen B Duffull, Joel Tarning, et al.
The AAPS Journal|July 25, 2014
Making the most of clinical data: reviewing the role of pharmacokinetic-pharmacodynamic models of anti-malarial drugsJulie A Simpson, Sophie Zaloumis, Alysha M DeLivera, et al.
Malaria Journal|October 28, 2017
Statistical methods to derive efficacy estimates of anti-malarials for uncomplicated Plasmodium falciparum malaria: pitfalls and challengesPrabin Dahal, Julie A Simpson, Grant Dorsey, et al.
Advances in Parasitology|December 4, 2012
Chemotherapeutic strategies for reducing transmission of Plasmodium vivax malariaNicholas M Douglas, George K John, Lorenz von Seidlein, et al.
BMC Medical Research Methodology|November 29, 2019
Dealing with indeterminate outcomes in antimalarial drug efficacy trials: a comparison between complete case analysis, multiple imputation and inverse probability weightingPrabin Dahal, Kasia Stepniewska, Philippe J Guerin, et al.
Malaria Journal|October 31, 2021
Opening the policy blackbox: unravelling the process for changing national diagnostic and treatment guidelines for vivax malaria in seven countriesVarunika Ruwanpura, Josselyn Neukom, Koen Peeters Grietens, et al.
Pageof 35